Why Tirzepatide Is Superior to Retatrutide: The GIP Advantage for Insulin Sensitivity and Beyond In the rapidly advancing field of metabolic therapies, Tirzepatide (Mounjaro/Zepbound) and the investigational Retatrutide stand out as powerful tools for treating obesity, type 2 diabetes, and insulin resistance. While both deliver impressive results, Tirzepatide holds a clear edge thanks to its…
Read more
Why Tirzepatide Is Superior to Retatrutide: The GIP Advantage for Insulin Sensitivity and Beyond




